2022 International Virtual Conference
on Human Retrovirology: HTLV 2022
8 - 11 May 2022

On behalf of the HTLV 2022 Scientific Committee, we would like to thank you for promoting the 20th International Virtual Conference on Human Retrovirology: HTLV and Related Viruses (HTLV 2022). We have created this Digital Toolkit to help you get the most from your involvement in this year’s conference. 

The below files can be used on promotional material to signify your involvement in HTLV 2022. You can use the conference logo or web banner in your emails, on your website, in your newsletters, in print advertising and other promotional material. The PowerPoint slide can be added to presentations. Email the Save the Date flyer to your networks or print some copies and have them available in your organisation’s offices. Please always link back to htlvconference2022.com when using any of the promotional materials. 

You can include the key information about the 2022 HTLV Conference when using the digital promotional assets in this toolkit:

The 2022 International Virtual Conference on Human Retrovirology: HTLV and Related Viruses aims to focus on Oceania and especially Australia for the first time in the history of this conference. In 2022 we aim to emphasise the need to increase HTLV-1 public health and social science research output in the global response to HTLV-1.

This new emphasis is a direct response to the World Health Organisation’s (WHO) recent global consultation on HTLV-1 that called for global initiatives to reduce the HTLV-1 burden.

The HTLV 2022 conference is hosted virtually by Melbourne, Australia on behalf of IRVA, The International Retrovirology Association and will be in Australian Eastern Standard Time. We hope to announce a face to face Melbourne hub for those able to travel pending the evolving COVID-19 pandemic in Australia.

Conference objectives

  • To proactively incorporate social and public health science on the HTLV research agenda
  • To discuss and develop strategies and initiatives for improved patient outcome while being inclusive of the patient perspective
  • To showcase the latest research and findings on HTLV across multiple disciplines: clinical, science and social science encouraging networking
  • To develop a conference report to be published in a high impact scientific journal for wide dissemination
  • To invite key government and institutional decision makers to adopt HTLV-1 as one of their health promotion goals

 Australia specific objectives

  • To highlight Australian research within the conference program to showcase that Australia is in a strong position to conduct research on HTLV
  • To engage with WHO
Copyright 2021 by ASHM Conference & Events Division | info@htlvconference2022.com | +61 2 8204 0770